You're reading the free version. Trader adds the live tape and alerts.
Start tracking
HRTX Exercise Disclosure
Duarte Ira · SEC Form 4 · Filed Jul 20, 2026
Exercise
Reported value range
Not reported
Duarte Ira EVP, Chief Financial Officer
HRTX
Heron Therapeutics
HRTX
Transaction date
Jul 19, 2026
Public filing date
Jul 20, 2026
Filing lag
Filed 1 day later
HRTX daily price context
Close on/before transaction
$0.47
Jul 17, 2026
First close after public filing
$0.48
Jul 20, 2026
30-day return after filing
-34.45%
Through Aug 19, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 3,874 shares
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001193125-26-308887
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$517.47
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Heron Therapeutics, Inc. /De/ HRTX Current | Exercise | Jul 19, 2026 | Not reported |
| Heron Therapeutics, Inc. /De/ HRTX | Disposition | Jul 19, 2026 | $517.47 |
| Heron Therapeutics, Inc. /De/ HRTX | Exercise | Jul 19, 2026 | $0 |